Ângela Castela

1.3k total citations
22 papers, 834 citations indexed

About

Ângela Castela is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Ângela Castela has authored 22 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Genetics. Recurrent topics in Ângela Castela's work include Sexual function and dysfunction studies (6 papers), Diabetes and associated disorders (5 papers) and Pancreatic function and diabetes (5 papers). Ângela Castela is often cited by papers focused on Sexual function and dysfunction studies (6 papers), Diabetes and associated disorders (5 papers) and Pancreatic function and diabetes (5 papers). Ângela Castela collaborates with scholars based in Portugal, Belgium and Italy. Ângela Castela's co-authors include Carla Costa, Décio L. Eizirik, Raquel Soares, Pedro Vendeira, Piero Marchetti, Alexandra Coomans de Brachène, Lorella Marselli, C. Paul, Máikel L. Colli and E. Archier and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Science Advances.

In The Last Decade

Ângela Castela

22 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ângela Castela Portugal 15 237 229 201 168 156 22 834
Jianzhong Zhang China 20 135 0.6× 80 0.3× 118 0.6× 110 0.7× 420 2.7× 75 1.1k
S. M. Zhang United States 9 98 0.4× 250 1.1× 139 0.7× 94 0.6× 170 1.1× 12 1.3k
Zheng Lu China 20 177 0.7× 87 0.4× 108 0.5× 141 0.8× 458 2.9× 67 1.2k
Dongzi Yang China 28 209 0.9× 188 0.8× 22 0.1× 36 0.2× 371 2.4× 80 2.0k
Maurizio Guido Italy 23 369 1.6× 59 0.3× 24 0.1× 93 0.6× 189 1.2× 94 1.7k
Elena Maneschi Italy 16 532 2.2× 45 0.2× 199 1.0× 102 0.6× 133 0.9× 17 1.0k
Mansour A. Alghamdi Saudi Arabia 15 31 0.1× 46 0.2× 56 0.3× 64 0.4× 253 1.6× 100 753
J J Kim South Korea 8 39 0.2× 87 0.4× 128 0.6× 84 0.5× 168 1.1× 8 478
R. Tenaglia Italy 18 71 0.3× 57 0.2× 45 0.2× 137 0.8× 331 2.1× 64 841
Abdullah Taşlıpınar Türkiye 15 320 1.4× 106 0.5× 37 0.2× 62 0.4× 224 1.4× 47 800

Countries citing papers authored by Ângela Castela

Since Specialization
Citations

This map shows the geographic impact of Ângela Castela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ângela Castela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ângela Castela more than expected).

Fields of papers citing papers by Ângela Castela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ângela Castela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ângela Castela. The network helps show where Ângela Castela may publish in the future.

Co-authorship network of co-authors of Ângela Castela

This figure shows the co-authorship network connecting the top 25 collaborators of Ângela Castela. A scholar is included among the top collaborators of Ângela Castela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ângela Castela. Ângela Castela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rana, Jyoti, Ângela Castela, Sofia Thomaidou, et al.. (2023). 25-OR: ADA Presidents' Select Abstract: Preclinical Evaluation of TYK2 Inhibitors in Type 1 Diabetes. Diabetes. 72(Supplement_1). 1 indexed citations
2.
Alvelos, Maria Inês, Ângela Castela, Stéphane Demine, et al.. (2022). Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic β cells. Science Advances. 8(37). eabn5732–eabn5732. 20 indexed citations
3.
Brachène, Alexandra Coomans de, José Maria Costa-Júnior, Ângela Castela, et al.. (2022). Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes. Diabetologia. 66(3). 450–460. 21 indexed citations
4.
Cohen‐Fultheim, Roni, Sofia Thomaidou, Alexandra Coomans de Brachène, et al.. (2022). ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation. Frontiers in Endocrinology. 13. 1058345–1058345. 12 indexed citations
5.
Brachène, Alexandra Coomans de, et al.. (2021). Endogenous mitochondrial double‐stranded RNA is not an activator of the type I interferon response in human pancreatic beta cells. PubMed. 12(1). 6–6. 7 indexed citations
6.
Alvelos, Maria Inês, Ângela Castela, Bianca Marmontel de Souza, et al.. (2021). A functional genomic approach to identify reference genes for human pancreatic beta cell real-time quantitative RT-PCR analysis. Islets. 13(3-4). 51–65. 9 indexed citations
7.
Alvelos, Maria Inês, F.X. Reymond Sutandy, Jonàs Juan‐Mateu, et al.. (2020). The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells. Life Science Alliance. 4(3). e202000825–e202000825. 14 indexed citations
8.
Brachène, Alexandra Coomans de, Ângela Castela, Anne Op De Beeck, et al.. (2020). Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta‐cell protection in type 1 diabetes. Diabetes Obesity and Metabolism. 22(10). 1827–1836. 26 indexed citations
9.
Colli, Máikel L., Jessica L. Hill, Laura Marroquí, et al.. (2018). PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction. EBioMedicine. 36. 367–375. 143 indexed citations
10.
Luís, Carla, Raquel Costa, Ilda Rodrigues, et al.. (2018). Xanthohumol and 8-prenylnaringenin reduce type 2 diabetes–associated oxidative stress by downregulating galectin-3. Porto Biomedical Journal. 4(1). e23–e23. 23 indexed citations
12.
Castela, Ângela & Carla Costa. (2016). Molecular mechanisms associated with diabetic endothelial–erectile dysfunction. Nature Reviews Urology. 13(5). 266–274. 126 indexed citations
13.
Castela, Ângela, Pedro Gomes, Ricardo Silvestre, et al.. (2016). Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant Is Glycemic Control?. Journal of Cellular Biochemistry. 118(1). 82–91. 11 indexed citations
15.
Devaux, S., Ângela Castela, E. Archier, et al.. (2012). Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review. Journal of the European Academy of Dermatology and Venereology. 26(s3). 52–60. 34 indexed citations
16.
Devaux, S., Ângela Castela, E. Archier, et al.. (2012). Adherence to topical treatment in psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 26(s3). 61–67. 163 indexed citations
17.
Ribeiro, Ricardo, Cátia Monteiro, Ricardo Silvestre, et al.. (2012). Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma. Experimental Biology and Medicine. 237(10). 1155–1162. 26 indexed citations
18.
Castela, Ângela, Pedro Vendeira, & Carla Costa. (2011). Testosterone, Endothelial Health, and Erectile Function. SHILAP Revista de lepidopterología. 2011. 1–7. 13 indexed citations
19.
Castela, Ângela, Raquel Soares, Rui Medeiros, et al.. (2011). Differentially expressed angiogenic genes in diabetic erectile tissue — Results from a microarray screening. Molecular Genetics and Metabolism. 105(2). 255–262. 14 indexed citations
20.
Castela, Ângela, et al.. (2010). Erectile tissue molecular alterations with aging—differential activation of the p42/44 MAP Kinase pathway. AGE. 33(2). 119–130. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026